Perbak Capital Partners’s Lam Research LRCX Stock Holding History

Perbak Capital Partners’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,943	Closed	-$214K	–	310
2025 Q1	$214K	Buy	+2,943	New	+$232K	0.16%	178

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perbak Capital Partners's LRCX Position: Q2 2025 in Review

Perbak Capital Partners sold out of Lam Research (LRCX) in Q2 2025, closing a stake of 2,943 shares — an estimated $214K sold.

Perbak Capital Partners first reported a position in LRCX in Q1 2025 and held it in 1 quarter. The position peaked at $214K in Q1 2025. 1,878 funds tracked by Wall St. Rank hold LRCX as of Q2 2025.

Perbak Capital Partners reported no remaining Lam Research position as of Q2 2025 after selling out during the quarter.
Perbak Capital Partners sold 2,943 Lam Research shares in Q2 2025, an estimated $214K.
Perbak Capital Partners first reported a position in Lam Research in Q1 2025 and held it in 1 quarter.
Perbak Capital Partners's Lam Research position peaked at $214K in Q1 2025.
1,878 funds tracked by Wall St. Rank held Lam Research as of Q2 2025.

Based on Perbak Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.